Fiducial markers in prostate for kV imaging: quantification of visibility and optimization of imaging conditions
Authors:
- Yu ChenYCYu Chen
- John J O’connellJOJohn J O’connell
- Christine J KoCKChristine J Ko
- Rulon R MayerRMRulon R Mayer
- Arnaud BelardABArnaud Belard
- James E McDonoughJMJames E McDonough
- 30 November 2011
- journal article
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 57 (1) , 155-172
Abstract
The purpose of this work is to investigate possible smaller, less-dense fiducial markers implantable into the prostate for target localization and patient repositioning verification in an on-board kV-kV imaging system on a proton gantry. The experiments used a pelvic phantom and a variety of commercially available fiducial markers: CIVCO carbon marker of ϕ; 1 × 3 mm, gold seed markers of ϕ; 0.8 × 3 mm and ϕ; 1.2 × 3 mm, and IBA Visicoil helical gold linear markers in diameters of 0.35, 0.50, 0.75 and 1.15 mm. Two orthogonal on-board kV imagers were arranged for digital radiographic imaging of the phantom through the lateral and anterior-posterior directions. The contrast-to-noise ratio (CNR) for a given marker was calculated and used as a quantitative measure of its visibility. The patient entrance skin exposure (ESE) was measured and parameterized for kVp, mAs and source-to-surface distance. The ratio of CNR to ESE was first introduced to characterize the efficiency for imaging a marker using a given x-ray technique in order to optimize the marker's visibility and simultaneously minimize the x-ray imaging dose. If CNR > 2, which corresponds to a significance p < 0.05, is required for acceptable visibility, the carbon marker and the smallest Visicoil marker are not suitable for imaging through dense bone but the others are capable of being employed in the clinic. It is predicted that other markers in development should have a greater thickness than equivalent of 0.14 mm thick gold in order to produce the acceptable visibility in the lateral kV imaging. The linear Visicoil marker of ϕ; 0.50 × 5 mm is most suitable for kV imaging in the prostate for proton therapy as it induces the least proton dose perturbation amongst the acceptable markers. An optimal range of 120-130 kVp and 40-80 mAs is determined using the maximal CNR/ESE and CNR > 2 for laterally imaging this marker in the prostate.Keywords
This publication has 21 references indexed in Scilit:
- Dose perturbations and image artifacts caused by carbon-coated ceramic and stainless steel fiducials used in proton therapy for prostate cancerPhysics in Medicine & Biology, 2010
- Effectiveness of Using Fewer Implanted Fiducial Markers for Prostate Target AlignmentInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Dose perturbations from implanted helical gold markers in proton therapy of prostate cancerJournal of Applied Clinical Medical Physics, 2009
- Does Image-Guided Radiotherapy Improve Toxicity Profile in Whole Pelvic-Treated High-Risk Prostate Cancer? Comparison Between IG-IMRT and IMRTInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- A monoscopic method for real-time tumour tracking using combined occasional x-ray imaging and continuous respiratory monitoringPhysics in Medicine & Biology, 2008
- Prostate Localization Using Serrated Gold Coil MarkersInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Intensity-Modulated Radiotherapy Using Implanted Fiducial Markers With Daily Portal Imaging: Assessment of Prostate Organ MotionInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- On-line aSi portal imaging of implanted fiducial markers for the reduction of interfraction error during conformal radiotherapy of prostate carcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- Medical Imaging Physics2002
- An accurate method for computer‐generating tungsten anode x‐ray spectra from 30 to 140 kVMedical Physics, 1997